0 supp fig 1 cardiacpulm pre - centers for disease control

14
Figure S1 A B C D 2000 2010 2008 2006 2004 2002 2000 2010 2008 2006 2004 2002 2000 2010 2008 2006 2004 2002 2000 2010 2008 2006 2004 2002 Year Year Year Year Valvular Heart Dz Valvular Hrt Disease rate per 1000 deliveries 2 8 6 4 10 Congenital Hrt Disease rate per 1000 deliveries 2 8 6 4 10 Conduction d/o Conduction disorders rate per 1000 deliveries 2 8 6 4 10 History ischemic hrt dz rate per 1000 deliveries E F 2000 2010 2008 2006 2004 2002 2000 2010 2008 2006 2004 2002 Year Year Asthma rate per 1000 deliveries 10 40 30 20 Pulm Circ disorder rate per 1000 deliveries Asthma Pulmonary Circ 0.2 0.6 0.4 0 0 0 0 0 Congenital Heart Dz Ischemic Hrt Dz 0.2 0.6 0.4 0 Trends in the prevalence of pre-existing medical conditions and obstetric conditions at delivery admissions, the 2000 – 2009 Nationwide Inpatient Sample (n = 43,226,239). See Table S2 for linear regression results. (Abbreviations: APS=antiphospholipid antibody syndrome, DM=diabetes, FGR=fetal growth restriction, GDM=gestational diabetes, HTN=hypertension, IUFD=intrauterine fetal demise, Prex=preeclampsia, Rheum Arth=rheumatoid arthritis, SLE=systemic lupus erythematosus)

Upload: others

Post on 13-Jan-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

Figure S1

A B

C D

2000 20102008200620042002 2000 20102008200620042002

2000 20102008200620042002 2000 20102008200620042002

Year Year

Year Year

Valvular Heart Dz

Valv

ular

Hrt

Dis

ease

rate

per 1

000

deliv

erie

s

2

8

6

4

10

Cong

enita

l Hrt

Dis

ease

rate

per 1

000

deliv

erie

s

2

8

6

4

10

Conduction d/o

Cond

uctio

n di

sord

ers

rate

per 1

000

deliv

erie

s

2

8

6

4

10

His

tory

isch

emic

hrt

dz

rate

per 1

000

deliv

erie

s

E F

2000 20102008200620042002 2000 20102008200620042002

Year Year

Ast

hma

rate

per 1

000

deliv

erie

s

10

40

30

20

Pulm

Circ

dis

orde

r rat

epe

r 100

0 de

liver

iesAsthma Pulmonary Circ

0.2

0.6

0.4

0

00

0

0

Congenital Heart Dz

Ischemic Hrt Dz

0.2

0.6

0.4

0

Trends in the prevalence of pre-existing medical conditions and obstetric conditions at deliveryadmissions, the 2000 – 2009 Nationwide Inpatient Sample (n = 43,226,239). See Table S2 for linear regressionresults. (Abbreviations: APS=antiphospholipid antibody syndrome, DM=diabetes, FGR=fetal growth restriction, GDM=gestational diabetes, HTN=hypertension, IUFD=intrauterine fetal demise, Prex=preeclampsia, Rheum Arth=rheumatoid arthritis, SLE=systemic lupus erythematosus)

Figure S1 continued

G H

I J

2000 20102008200620042002 2000 20102008200620042002

2000 20102008200620042002 2000 20102008200620042002

Year Year

YearYear

Dia

bete

s ra

tepe

r 100

0 de

liver

ies

10

5

0

15

Thyr

oid

diso

rder

rate

per 1

000

deliv

erie

s

SLE

rate

per 1

000

deliv

erie

s

0

1.5

1.0

0.5

2.0Rh

eum

atoi

d ar

thrit

is ra

tepe

r 100

0 de

liver

ies

DM (non-gestational) Thyroid d/o

20

15

10

25

SLE Rheum Arth

0

1.5

1.0

0.5

2.0

K

2000 20102008200620042002

Year

Thro

mbo

phili

a ra

tepe

r 100

0 de

liver

ies

2

0

10Thrombophilia/APS

4

6

8

L

2000 20102008200620042002

Year

Thro

mbo

cyto

peni

a ra

tepe

r 100

0 de

liver

ies

Thrombocytopenia

2

0

10

4

6

8

Figure S1 continued

M N

2000 20102008200620042002 2000 20102008200620042002

Year

Ane

mia

rate

per 1

000

deliv

erie

s

Chro

nic

hype

rten

sion

rate

per 1

000

deliv

erie

s

Anemia Chronic HTN

60

120

100

80

5

20

15

10

O

2000 20102008200620042002

Year

Chro

nic

rena

l fai

lure

rate

per 1

000

deliv

erie

s

0

1.5

1.0

0.5

2.0Chronic Renal Failure

P

2000 20102008200620042002

Year

Toba

cco

rate

per 1

000

deliv

erie

s

20

80

60

40

Tobacco

Q R

2000 20102008200620042002 2000 20102008200620042002

Year

Dru

g us

e ra

tepe

r 100

0 de

liver

ies

5

0

20

Alc

ohol

use

rate

per 1

000

deliv

erie

s

10

15

Drug use Alcohol use

5

0

20

10

15

0

25

Figure S1 continued

S T

U

2000 20102008200620042002 2000 20102008200620042002

2000 20102008200620042002

Year Year

Ges

tatio

nal d

iabe

tes

rate

per 1

000

deliv

erie

s

Pree

clam

psia

rate

per 1

000

deliv

erie

s

Mul

tiple

ges

tatio

n ra

tepe

r 100

0 de

liver

ies

GDM

30

60

70

50

40

Prex

50

70

80

90

60

Multiple gestation

0

10

20

30

40

V

2000 20102008200620042002

Feta

l gro

wth

rest

rictio

n ra

tepe

r 100

0 de

liver

ies

0

10

20

30

40 FGR

W

2000 20102008200620042002

Abr

uptio

n ra

tepe

r 100

0 de

liver

ies

0

10

20

30

40

X

2000 20102008200620042002

Feta

l dea

th ra

tepe

r 100

0 de

liver

ies

2

3

4

5

6

Abruption IUFD7

Year Year

Year Year

Figure S2

A B

2000 20102008200620042002 2000 20102008200620042002

Myo

card

ial i

nfar

ctio

n ra

tepe

r 100

0 de

liver

ies

Vent

ricul

ar �

brill

atio

n ra

tepe

r 100

0 de

liver

ies

0

0.3

0.4

0.2

0.1

Myocardial infarction

Year

Ventricular fibrillation

Year

0.5

0

0.3

0.4

0.2

0.1

0.5

C D

2000 20102008200620042002 2000 20102008200620042002

Card

iac

arre

st ra

tepe

r 100

0 de

liver

ies

Acut

e he

art f

ailu

re ra

tepe

r 100

0 de

liver

ies

0

0.3

0.4

0.2

0.1

Year Year

0.5

0

0.3

0.4

0.2

0.1

0.5Cardiac Arrest

Acute heart failure

E F

2000 20102008200620042002 2000 20102008200620042002

Pneu

mon

ia ra

tepe

r 100

0 de

liver

ies

RDS

rate

per 1

000

deliv

erie

s

0

0.4

0.6

0.2

Year Year

0.8 Pneumonia

0

0.4

0.6

0.2

0.8 RDS

Trends in the incidence of medical events and complications occurring at delivery admissions, the 2000 – 2009Nationwide Inpatient Sample (n = 43,226,239). See Table S3 for linear regression results. (Abbreviations:CVA=cerebral vascular accident, DVT=deep vein thrombosis, PP=postpartum, RDS=respiratory distress syndrome)

Figure S2 continued

G H

2000 20102008200620042002 2000 20102008200620042002

Pulm

onar

y ed

ema

rate

per 1

000

deliv

erie

s

Stro

ke/C

VA ra

tepe

r 100

0 de

liver

ies

Year Year

I J

2000 20102008200620042002 2000 20102008200620042002

Pulm

onar

y em

bolis

m ra

tepe

r 100

0 de

liver

ies

DVT

rate

per 1

000

deliv

erie

s

Year Year

K L

2000 20102008200620042002 2000 20102008200620042002

Seps

is ra

tepe

r 100

0 de

liver

ies

In�u

enza

rate

per 1

000

deliv

erie

s

0

0.4

0.6

0.2

Year Year

0.8

0

0.4

0.6

0.2

0.8

Pulmonary edema

0

0.4

0.6

0.2

0.8Stroke/CVA

0

0.4

0.6

0.2

0.8

Pulmonary emobolism

0

0.4

0.6

0.2

0.8DVT

0

0.4

0.6

0.2

0.8

Sepsis Influenza

Figure S2 continued

M N

2000 20102008200620042002 2000 20102008200620042002

PP b

acte

rial i

nf ra

tepe

r 100

0 de

liver

ies

Acut

e re

nal f

ailu

re ra

tepe

r 100

0 de

liver

ies

Year Year

0

20

30

10

40

0

0.4

0.6

0.2

0.8PP Bacterial Infection Acute renal failure

Figure S3

A B

D

E

2000 20102008200620042002 2000 20102008200620042002

2000 20102008200620042002

2000 20102008200620042002

Year Year

Year

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2Ca

rdio

myo

path

y ra

tepe

r 100

0 de

liver

ies

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

F

2000 20102008200620042002

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

CMCM w/out ValvHrtDz

CMCM w/out Conduction d/o

CMCM w/out Asthma

C

CMCM w/out Ischemic Hrt Dx

2000 20102008200620042002

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

CM w/out CHDCM

CMCM w/out Pulm Circ

Trends in the prevalence of cardiomyopathy in women without the listed pre-existing medical conditionscompared to all women with cardiomyopathy at delivery admissions, the 2000 – 2009 Nationwide InpatientSample (n=43,226,239). To determine if pre-existing medical conditions occurring during a delivery admissionwere accounting for the increased prevalence of cardiomyopathy over the study period, the linear trend forcardiomyopathy among women who also did not have each of the listed preexisting medical conditions listedwere compared to the linear trend for all women with cardiomyopathy (CM). The di�erences in the two slopeswere compared and are presented in Tables 1 and 2. Only chronic hypertension was found to be associated withthe increasing incidence of cardiomyopathy at a delivery admission (Figure 2, Table 1). (Abbreviations: CHD=congenital heart disease, CM=cardiomyopathy, DM=diabetes, d/o=disorder, FGR=fetal growth restriction, GDM=gestational diabetes, IUFD=intrauterine fetal demise, RA=rheumatoid arthritis, SLE=systemic lupus erythematosus, VavlHrtDz=valvular heart disease)

Figure S3 continued

H

I J

K

2000 20102008200620042002

2000 20102008200620042002 2000 20102008200620042002

2000 20102008200620042002

Year

Year Year

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

L

2000 20102008200620042002

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

sCMCM w/out SLE

CMCM w/out RA

CMCM w/out Thrombophilia

CMCM w/out Thrombocytopenia

2000 20102008200620042002

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s CMCM w/out Thyroid

G

CMCM w/out DM

Figure S3 continued

M N

O

R

2000 20102008200620042002 2000 20102008200620042002

2000 20102008200620042002

2000 20102008200620042002

Year Year

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

CMCM w/out Tobacco

CMCM w/out Drug Use

CMCM w/out Alcohol Use

Q

CMCM w/out Prex

2000 20102008200620042002

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

P

2000 20102008200620042002

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

CM w/out Chronic renal failureCM

Year

CMCM w/out Anemia

Figure S3 continued

U V

2000 20102008200620042002 2000 20102008200620042002

Year Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s CMCM w/out Abruption

T

2000 20102008200620042002

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

sCMCM w/out FGR

S

2000 20102008200620042002

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s CMCM w/out Multiple Gest

CMCM w/out GDM

W

2000 20102008200620042002

Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s CMCM w/out IUFD

Figure S4

A B

C D

2000 20102008200620042002 2000 20102008200620042002

2000 20102008200620042002 2000 20102008200620042002

Year Year

Year Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2Ca

rdio

myo

path

y ra

tepe

r 100

0 de

liver

ies

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

E F

2000 20102008200620042002 2000 20102008200620042002

Year Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

CMCM w/out MI

CMCM w/out Vent Fib

CMCM w/out Cardiac arrest

CMCM w/out Acute Hrt Failure

CMCM w/out Pneumonia

CMCM w/out RDS

Trends in the prevalence of cardiomyopathy in women without the listed medical complication compared to allwomen with cardiomyopathy at delivery admissions, the 2000 – 2009 Nationwide Inpatient Sample (n=43,226,239).To determine if medical complications occurring during a delivery admission were accounting for the increasedprevalence of cardiomyopathy over the study period, the linear trend for cardiomyopathy among women whoalso did not have each of the listed medical complications listed were compared to the linear trend for all womenwith cardiomyopathy (CM). The di�erences in the two slopes were compared and are presented in Table 3. Noneof the changes in the incidence of the listed medical complications were found to be associated with the increasingprevalence of cardiomyopathy (Table 3). (Abbreviations: CVA=cerebral vascular accident, DVT=deep veinthrombosis, MI=myocardial infarction, PP=postpartum, Pulm Edema=pulmonary edema, Pulm Embolism=pulmonary embolism, RDS=respiratory distress syndrome, Vent Fib=ventricular �brillation)

Figure S4 continued

G H

I J

2000 20102008200620042002 2000 20102008200620042002

2000 20102008200620042002 2000 20102008200620042002

Year Year

Year Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

K L

2000 20102008200620042002 2000 20102008200620042002

Year Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

CMCM w/out Pulm Edema

CMCM w/out CVA/Stroke

CMCM w/out Pulm Embolism

CMCM w/out DVT

CMCM w/out Sepsis

CMCM w/out Influenza

Figure S4 continued

M N

2000 20102008200620042002 2000 20102008200620042002

Year Year

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

s

0

0.6

0.4

0.2

Card

iom

yopa

thy

rate

per 1

000

deliv

erie

sCMCM w/out PP Bact Infection

CMCM w/out Acute Renal Failure